Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), sold 6,186 shares at $49.43 ($307K) on 2013-04-08, disclosed to the SEC on 2013-04-10.
Scheduled sale ($307k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.43 | 5,107 | $252K | 82.3% |
| 2 | $50.26 | 1,079 | $54K | 17.7% |
| Total | $49.57 avg | 6,186 | $307K | 100% |
| Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |
| SLXP | BUY | 2011-08-11 | $21K | — | Filing → |